Why is P & G Health Ltd falling/rising?

As of 17-Sep, Procter & Gamble Health Ltd is experiencing a decline in its stock price, currently at 6,330.00, which reflects a decrease of 7.5 or 0.12%. The stock has shown a trend reversal, falling after two consecutive days of gains. Despite this recent decline, the stock has performed well over the longer term, with a year-to-date return of 21.03% and a one-year return of 23.27%. The stock is currently trading above its 50-day, 100-day, and 200-day moving averages, although it is below its 5-day and 20-day moving averages. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 38.37% against the 5-day average, indicating a healthy level of trading activity. The company boasts high management efficiency with a return on equity (ROE) of 32.32% and has maintained a low debt-to-equity ratio, which supports its financial stability.
In the broader market context, the stock's short-term performance has lagged behind the benchmark, with a 1-week return of 0.11% compared to the Sensex's 1.56%. While the company has demonstrated strong fundamentals, including consistent positive results over the last four quarters and high institutional holdings at 21.15%, there are concerns regarding its long-term growth potential, as net sales have only grown at an annual rate of 7.39% over the past five years. Furthermore, the stock's valuation appears expensive with a price-to-book value of 19.6, despite trading at a discount compared to its peers' historical valuations. These mixed signals contribute to the stock's recent price movement, reflecting both its strong performance and underlying risks.